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1726-4Is cloud-based technology a promising tool in the integrated care
of patients with chronic kidney disease?Chronic kidney disease (CKD) is one of the most prevalent
noncommunicable diseases in Taiwan.1 Previous studies have
provided solid evidence of an association between CKD and
the increased risk of death, cardiovascular event and end-stage
renal disease.2 In recent years, albuminuria has also been
recognized as another major risk factor for cardiovascular
disease and CKD progression.2 Together, CKD and albu-
minuria are multiplicatively associated with an increased risk
of mortality.3
Currently, the principle approach to lowering the risk of
kidney failure and major cardiovascular event in CKD patients
with overt proteinuria is intensive blood pressure (BP) con-
trol.4,5 The 2012 Kidney Disease Improving Global Outcomes
(KDIGO) clinical practice guideline suggests an appropriate
BP control target level is consistently  130/80 mmHg in
CKD patients with urine albumin excretion > 300 mg/day,6
although different targets may be recommended by others.7
Despite the importance of BP control, in one cohort study,
only 26% of CKD patients achieved the BP goal suggested by
Joint National Committee 7 guidelines.8 An extensive
Cochrane review concluded that home BP monitoring, coupled
with an appointment reminder system may help patients
improve blood pressure control.9 However, the results require
further evaluation and most of the trials excluded patients with
moderate-to-severe kidney disease.
In this issue of the Journal of the Chinese Medical Associ-
ation, Lin et al10 report a randomized trial comparing two
models of home BP monitoring in hypertensive CKD patients.
Forty-eight hypertensive patients were included, each with an
estimated glomerular filtration rate < 60 mL/minute/1.73m2.
Twenty-five patients were randomly assigned to the inter-
vention group, where cloud-based manometers integrated with
a physician order entry system were applied. Physicians at least
weekly reviewed the BP records of patients in the study, and the
patients were recalled to the clinic as needed. The other group
of patients in the study used the regular home BP recording
sheets and had medical adjustment during routine outpatient
visit. During the 6-month study period, BP, serum creatinine
(Cr), and the spot urine proteinuriaeCr ratio (UTP/UCr) were
assessed at baseline and every 3 months. Several patients were
lost in follow-up after the enrollment, such that the final anal-
ysis included 18 patients from both groups.x.doi.org/10.1016/j.jcma.2014.09.009
901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical AssThe baseline characteristics between the two groups were
comparable in sex, age, CKD stages, body mass index, esti-
mated glomerular filtration rate, Cr, hematocrit, albumin,
cholesterol, UTP/UCr, morning BP, and nighttime BP. At
6 months, the nighttime systolic BP (128.1 ± 13.5 mmHg vs.
138.7 ± 9.2 mmHg) and diastolic BP (72.1 ± 5.5 mmHg vs.
75.9 ± 8.5 mmHg) were significantly lower in the intervention
group despite no difference in the morning BP. Besides, when
compared with the baseline values, the nighttime systolic and
diastolic BP were also significantly lowered in the intervention
group.
A recent randomized trial of 450 uncontrolled hypertensive
patients also showed a similar result, where 84 (18.6%) of
them were CKD.11 In that study, patients who received home
BP telemonitoring with pharmacist management realized more
substantial improvements in BP control and decreases in BP
than patients who received the usual care. During a 12-month
study period, greater antihypertensive medication intensifica-
tion was noted, as well as better self-reported adherence to
antihypertensive medication and sodium restrictions.
Among uncontrolled hypertensive patients, medical non-
compliance is one of several important factors.12 The benefi-
cial effect of home BP monitoring may be due to the
improvements in medical compliance and families’ partic-
ipation since they realized that BP levels were constantly
monitored by physicians. By contrast, although the frequency
of patients’ recall was not provided, a more timely assessment
and medical adjustment may also improve the outcome.
However, although nighttime BP was improved by the inter-
vention, the optimal goal of home BP control is still unknown.
The guidelines for BP management are derived from the
results of randomized control trials targeting BP in an office
environment. Discrepancies were noted between the office and
24-hour BP values in hypertensive populations.13 Measuring
the home BP is superior to office BP in reducing the mis-
classification of hypertension in patients with CKD.14 Some
evidence has also demonstrated that home BP is a significant
predictor of renal failure and death in CKD patients.15
Therefore, home BP monitoring may not only provide better
BP control, but also be useful for risk stratification in CKD
patients. However, whether it will translate into a better clin-
ical outcome is yet to be determined.ociation. All rights reserved.
609Editorial / Journal of the Chinese Medical Association 77 (2014) 608e609In this study,10 the serum Cr level was significantly lower in
the intervention group at the end of study (2.83 ± 2.0 mg/dl vs.
4.38± 3.0mg/dl). The possible explanations for thismay include
differences in the underlying patient diseases, the classes of
medications used by patients for BP control, or the achieved BP
values between the two groups. Although the levels of the UTP/
UCr between the two groups were insignificant, a lowering trend
was noted in the intervention group. The authors suggested that
the improvements of UTP/UCr from baseline may be associated
with the lower achieved night time BP. However, further corre-
lation analysis was needed to clarify this assumption.
This pilot study demonstrated a significant decrease in
nighttime BP in CKD patients by using cloud-base BP man-
ometers integrated with physician order systems. Compared to
the control group, serum Cr level was also lowered sig-
nificantly by this approach. However, some limitations should
be considered in interpreting the results. The sample size was
relatively small and thus the power of the analysis may be
compromised. The study was not blinded, and potential bias
may exist in the way physicians managed the BP values.
Several important baseline characteristics were not presented,
including the number of hypertensive drugs classes and the
nature of the underlying diseases. Further randomized con-
trolled trials with larger sample size and solid end-points are
needed. Additionally, such further studies could also examine
the cost-effectiveness and the patients’ acceptance of this
approach.
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